(Q38954156)

7 September 2017

Correlation of in vitro itraconazole and fluconazole susceptibility with clinical outcome for patients with vulvovaginal candidiasis (English)

1 reference

7 September 2017

1 reference

1 reference

Claudete Rodrigues Paula

5

object named as

Claudete Rodrigues Paula

0 references

author name string

Milce Costa

1

1 reference

7 September 2017

Xisto Sena Passos

2

1 reference

7 September 2017

André Thiago Borges Miranda

3

1 reference

7 September 2017

Rosane Silva Carneiro de Araújo

4

1 reference

7 September 2017

Claudete Rodrigues Paula

5

1 reference

7 September 2017

Maria do Rosário Rodrigues Silva

6

1 reference

7 September 2017

language of work or name

1 reference

1 January 2004

1 reference

7 September 2017

5

1 reference

inferred from page(s)

published in

Mycopathologia

1 reference

7 September 2017

157

1 reference

7 September 2017

43-47

1 reference

7 September 2017

1

1 reference

https://scigraph.springernature.com/pub.10.1023/b:myco.0000012220.09227.25

7 September 2017

0 references

cites work

Current and emerging azole antifungal agents

1 reference

12 December 2020

Multisite reproducibility of the Etest MIC method for antifungal susceptibility testing of yeast isolates.

1 reference

12 December 2020

Evaluation of Etest and macrodilution broth method for antifungal susceptibility testing of Candida sp strains isolated from oral cavities of AIDS patients.

1 reference

12 December 2020

Antifungal susceptibility testing of yeast isolates from blood cultures by microbroth dilution and the E test

1 reference

12 December 2020

Susceptibility testing of fungi: current status of correlation of in vitro data with clinical outcome

1 reference

12 December 2020

Efficacy of 7-day treatment with metronidazole+miconazole (Neo-Penotran) - a triple-active pessary for the treatment of single and mixed vaginal infections

1 reference

12 December 2020

Antifungal susceptibility testing: progress and future developments.

1 reference

12 December 2020

Comparative study on the effectiveness of antifungal agents in different regimens against vaginal candidiasis

1 reference

12 December 2020

Antifungal susceptibility testing using the E test: comparison with the broth macrodilution technique

1 reference

12 December 2020

Efficacy of Fluconazole in the Treatment of Upper Gastrointestinal Candidiasis in Neutropenic Patients with Cancer: Factors Influencing the Outcome

1 reference

12 December 2020

In-vitro susceptibility pattern of Candida lusitaniae and evaluation of the Etest method

1 reference

12 December 2020

Antifungal activities of fluconazole, caspofungin (MK0991), and anidulafungin (LY 303366) alone and in combination against Candida spp. and Crytococcus neoformans via time-kill methods

1 reference

12 December 2020

Evaluation of the Etest method for determining fluconazole susceptibilities of 402 clinical yeast isolates by using three different agar media

1 reference

12 December 2020

Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and candida infections. Subcommittee on Antifungal Susceptibility Te

1 reference

12 December 2020

In vitro activity of antimycotic agents determined by E-test method against vaginal Candida species

1 reference

12 December 2020

Evaluation of Etest for direct antifungal susceptibility testing of yeasts in positive blood cultures

1 reference

12 December 2020

10.1023/B:MYCO.0000012220.09227.25

Identifiers

DOI

1 reference

Dimensions Publication ID

7 September 2017

0 references

1 reference